Top Pre-Market Relative Volume Movers (SIOX, TDOC, RCMT...) On April 28, 2022

SIOX has already traded 2835.49 times its average pre-market volume of shares this morning and 2.25 times its average daily volume. During the last 20 trading days, SIOX has traded on average 204 shares during the pre-market and 257,155 shares daily.

Sio Gene Therapies Inc

SIOX has already traded 2835.49 times its average pre-market volume of shares this morning and 2.25 times its average daily volume.

During the last 20 trading days, SIOX has traded on average 204 shares during the pre-market and 257,155 shares daily.

SIOX is trading actively this pre-market session on news that "Shares of Sio Gene Therapies (SIOX) fell 24.8% to $0.45 in aftermarket trading on Wednesday, after the company terminated its licensing agreement with the University of Massachusetts…".

2. TDOC

Teladoc Health Inc

TDOC has already traded 274.23 times its average pre-market volume of shares this morning and 1.22 times its average daily volume.

Over the previous 20 trading days, TDOC has traded on average 14,862 shares during the pre-market and 3,327,664 shares daily.

TDOC is trading actively this morning after releasing news that "Teladoc Health Inc., the digital health provider that’s backed by Cathie Wood’s ARK Investment Management LLC, plunged after warning on cost inflation and a slowdown in sales.".

3. RCMT

RCM Technologies, Inc.

RCMT has currently traded 108.07 times its average pre-market volume of shares this morning and 0.50 times its average daily volume.

Over the previous 20 trading days, RCMT has traded on average 697 shares during the pre-market and 150,403 shares daily.

RCMT is trading actively this pre-market session after releasing news that "Gainers: RCM Technologies (RCMT) +25%. Meta Platforms (FB) +20%".

4. AREC

American Resources Corporation - Class A

AREC has already traded 33.15 times its average pre-market volume of shares this morning and 0.43 times its average daily volume.

For the preceding 20 trading days, AREC has traded on average 16,548 shares during the pre-market and 1,272,376 shares daily.

AREC is moving this morning after reporting news that "Founded in 2019, the global Rare Earth Industry Association (REIA) is an international non-profit organization representing the global REE industry.FISHERS, IN / ACCESSWIRE / April 27, 2022 / American Resources Corporation (NASDAQ:AREC) ("American …".

5. FENC

Fennec Pharmaceuticals Inc

FENC has presently traded 5.82 times its average pre-market volume of shares this morning and 0.36 times its average daily volume.

Over the previous 20 trading days, FENC has traded on average 2,112 shares during the pre-market and 34,335 shares daily.

FENC is trading actively this pre-market session after reporting news that "Fennec Pharmaceuticals Inc. (NASDAQ: FENC ) announced that the U.S. Food and Drug Administration (FDA) has accepted for filing of resubmitted New Drug Application (NDA) for PEDMARK TM (sodium thiosulfate) for the prevention of platinum-induced ototoxicity in pediatric patients one month to less than 18 years of age with localized, non-metastatic, solid tumors. The … Full story available on Benzinga.com".

6. FLWS

1-800 Flowers.com Inc. - Class A

FLWS has already traded 703.81 times its average pre-market volume of shares this morning and 0.34 times its average daily volume.

Over the past 20 trading days, FLWS has traded on average 315 shares during the pre-market and 657,388 shares daily.

FLWS is trading actively this morning after releasing news that "1-800 FLOWERS.COM press release (NASDAQ:FLWS): Q3 GAAP EPS of -$0.36 misses by $0.08.Revenue of $474.2M (flat Y/Y) misses by $8.88M.".

7. XELA

Exela Technologies Inc

XELA has currently traded 4.20 times its average pre-market volume of shares today and 0.33 times its average daily volume.

During the last 20 trading days, XELA has traded on average 2,854,860 shares during the pre-market and 36,693,030 shares daily.

XELA is trading actively today on news that "Exela Technologies (XELA) is trading 7.4% higher premarket after it signed a multi-year license deal with Finanz Informatik, the IT service provider of the Savings Banks Finance,…".

8. BTU

Peabody Energy Corp. New

BTU has already traded 30.01 times its average pre-market volume of shares today and 0.32 times its average daily volume.

During the previous 20 trading days, BTU has traded on average 89,509 shares during the pre-market and 8,510,924 shares daily.

BTU is moving this pre-market session after reporting news that "Peabody Energy Q1 Coal Revenue Rises 58%".

9. ARBK

Argo Blockchain Plc - ADR

ARBK has currently traded 18.12 times its average pre-market volume of shares this morning and 0.28 times its average daily volume.

Over the last 20 trading days, ARBK has traded on average 1,723 shares during the pre-market and 111,782 shares daily.

ARBK is trading actively today after reporting news that "The shares rose the most since March after the crypto miner said it expects its hashrate to reach 5.5 EH/s by the end of 2022.".

10. A

Agilent Technologies Inc.

A has currently traded 2489.01 times its average pre-market volume of shares this morning and 0.22 times its average daily volume.

For the preceding 20 trading days, A has traded on average 194 shares during the pre-market and 2,149,091 shares daily.

A is trading actively this morning after reporting news that "Dublin, April 28, 2022 (GLOBE NEWSWIRE) -- The "Next-Generation Gynecological Cancer Diagnostics Market - A Global Market and Regional Analysis: Focus on Technology, Product Type, End User, and Country Analysis - Analysis and Forecast, 2020-2031" report has been added to ResearchAndMarkets.com''s offering. In 2020, the global next-generation gynecological cancer diagnostics market was valued at $1,976.5 million, which is expected to reach $5,657.7 million by 2031, growing at a CAGR of 10.07% during the forecast period 2021-2031. The purpose of this study is to gain a holistic view of the next-generation gynecological cancer diagnostics market in terms of various influencing factors, such as recent trends, regulatory requirements, and technological advancements of the market. The study defines the products and services utilized for next-generation gynecological cancer diagnostics to improve prognosis and quality of life among women. Mutation molecular profiling is critical for the identification and characterization of unique mutations to facilitate disease manifestation and progression.".

Data provided by: relvol.com - Stock ScannerPrevious article:

ncG1vNJzZmihnquytMDEnWWbpJ%2BXe6S70Z5lsKGemby4v42nnK1nmaPDpr%2FTnptonZGnubp5zJqppJ2kYq6kwMivnGarpKSwrL%2BMmqeroZxif3l5kWlpaw%3D%3D

 Share!